Form EFFECT Silexion Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 18, 2026 9:00 A.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- "Northeast Super League" Ignites Dalian as the City's First Home Match Makes an Eagerly-Anticipated Debut
- Irby Celebrates 100 Years of Growth, Partnership and Industry Leadership
- Enduro Metals Outlines 2026 Exploration Program on Newmont Lake Project, British Columbia Initial 3,000 Metre Drill Program at the Andrei Copper-Gold Porphyry Target
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
